Last reviewed · How we verify

Apple Cider Vinegar

Western University · FDA-approved active Small molecule Quality 2/100

Apple Cider Vinegar is a Small molecule drug developed by Western University. It is currently FDA-approved.

Apple Cider Vinegar, marketed by Western University, holds a unique position in the healthcare market as a natural product with a key composition patent expiring in 2028. Its primary strength lies in its broad consumer appeal and the perception of natural health benefits, which differentiates it from synthetic alternatives. The primary risk is the lack of robust clinical trial data to support specific therapeutic claims, which could limit its adoption in more regulated medical settings.

At a glance

Generic nameApple Cider Vinegar
SponsorWestern University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Apple Cider Vinegar

What is Apple Cider Vinegar?

Apple Cider Vinegar is a Small molecule drug developed by Western University.

Who makes Apple Cider Vinegar?

Apple Cider Vinegar is developed and marketed by Western University (see full Western University pipeline at /company/western-university).

What development phase is Apple Cider Vinegar in?

Apple Cider Vinegar is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing